Approval · Notice of Compliance 2337 · 2001
REMICADE: Notice of Compliance 2337
Issued June 6, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2337
- Date
- June 6, 2001
- Company
- Centocor Inc.Leiden, --, Netherlands
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REMICADE | 02244016 | Marketed |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL